|
Market Closed -
NYSE
04:00:03 2026-10-27 pm EDT
|
5-day change | 1st Jan Change | ||
| 325.37 USD | -1.40% |
|
-5.21% | -3.67% |
| Oct. 21 | Cencora to buy American Oncology Network in $2.4 billion deal | RE |
| Oct. 21 | Baird Adjusts Price Target on Cencora to $375 From $373 | MT |
| Market Cap | 62.09B 55.73B 51.45B 46.66B 87.21B 5,898B 88.28B 617B 245B 3,091B 233B 228B 9,803B | P/E 2026 * |
17.8x | P/E 2027 * | 19.7x |
|---|---|---|---|---|---|
| Enterprise Value | 69.53B 62.4B 57.62B 52.25B 97.65B 6,604B 98.85B 691B 274B 3,462B 261B 255B 10,977B | EV / Sales 2026 * |
0.21x | EV / Sales 2027 * | 0.19x |
| Free-Float |
61.21% | Yield 2026 * |
0.73% | Yield 2027 * | 0.75% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| COR | Delayed | |
CBOE
| COR | Real-time | |
|
Mexican S.E.
| COR * | End-of-day quote | |
|
London S.E.
| 0HF3 | Delayed | |
|
Tradegate
| ABG | Real-time | |
|
Deutsche Boerse AG
| ABG | Delayed | |
|
Börse Stuttgart
| ABG | Delayed | |
|
Boerse Muenchen
| ABG | Real-time | |
|
Xetra
| ABG | Delayed | |
|
Wiener Boerse
| ABC | End-of-day quote | |
|
Borsa Italiana
| 1COR | End-of-day quote |
Last Transcript: Cencora, Inc.
| 1 day | -1.40% | ||
| 1 week | -5.21% | ||
| Current month | +8.37% | ||
| 1 month | +6.01% | ||
| 3 months | +4.57% | ||
| 6 months | +4.90% | ||
| Current year | -3.67% |
| 1 week | 325 |  | 344.43 |
| 1 month | 295.01 | | 345.46 |
| Current year | 244.82 | | 376.92 |
| 1 year | 244.82 | | 377.54 |
| 3 years | 182.75 | | 377.54 |
| 5 years | 113.68 | | 377.54 |
| 10 years | 68.7 | | 377.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Mauch
CEO | Chief Executive Officer | 59 | 2024-09-30 |
Eva Boratto
DFI | Director of Finance/CFO | 59 | 2026-06-28 |
Pawan Verma
CTO | Chief Tech/Sci/R&D Officer | 50 | 2024-11-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Lon Greenberg
BRD | Director/Board Member | 75 | 2013-05-15 |
Robert Mauch
BRD | Director/Board Member | 59 | 2024-09-30 |
D. Mark Durcan
CHM | Chairman | 64 | 2025-09-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/1/26 | Other | Director | 275 | 0.0001% | ||
| 10/1/26 | Sell | Controller/Auditor | -986 | 0.0005% | ||
| 10/1/26 | Other | Director | 197 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.40% | -5.21% | -3.18% | +73.40% | 62.09B | |
| -1.70% | +0.63% | -18.93% | +11.04% | 178B | |
| -1.54% | -0.98% | -21.45% | +15.09% | 116B | |
| -0.89% | -0.72% | -0.19% | +35.32% | 115B | |
| -0.19% | +4.40% | -42.85% | +7.83% | 93.1B | |
| +0.17% | -0.34% | +10.87% | +84.40% | 55.87B | |
| -0.69% | +0.63% | +4.27% | -22.48% | 53.12B | |
| -1.57% | +0.60% | -13.31% | +43.41% | 44.22B | |
| -0.54% | +2.43% | -3.67% | -9.31% | 33.59B | |
| -0.01% | -8.37% | +11.23% | -12.02% | 29.65B | |
| Average | -0.84% | +1.21% | -7.72% | +22.67% | 78.07B | |
| Weighted average by Cap. | -1.03% | +1.96% | -12.31% | +22.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 337B 302B 279B 253B 473B 32,013B 479B 3,349B 1,330B 16,780B 1,265B 1,238B 53,211B | 352B 316B 291B 264B 494B 33,405B 500B 3,494B 1,388B 17,509B 1,320B 1,292B 55,525B |
| Net income | 3.58B 3.21B 2.97B 2.69B 5.03B 340B 5.09B 35.57B 14.13B 178B 13.44B 13.15B 565B | 2.84B 2.55B 2.36B 2.14B 4B 270B 4.05B 28.27B 11.23B 142B 10.68B 10.45B 449B |
| Net Debt | 7.44B 6.67B 6.16B 5.59B 10.45B 706B 10.57B 73.89B 29.35B 370B 27.92B 27.32B 1,174B | 5.95B 5.34B 4.93B 4.47B 8.35B 565B 8.45B 59.08B 23.46B 296B 22.32B 21.84B 939B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-27 | $325.37 | -1.40% | 1,123,060 |
| 26-10-26 | $330.00 | -0.30% | 993,480 |
| 26-10-23 | $331.00 | -2.21% | 1,168,293 |
| 26-10-22 | $338.48 | -0.57% | 1,183,276 |
| 26-10-21 | $340.43 | -0.83% | 1,514,590 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COR Stock
Select your edition
All financial news and data tailored to specific country editions
